|
Herraiz C., Journé F., Ghanem G., Jiménez-Cervantes C., García-Borrón J.C. Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. International Journal of Biochemistry and Cell Biology. December 2012. 44:2244-2252. 10.1016/j.biocel.2012.09.008
AÑO: 2012; IF: 4.152
|
23000456
|
Herraiz C., Sánchez-Laorden B., Jiménez-Cervantes C., García-Borrón J. N-glycosylation of the human melanocortin 1 receptor: Occupancy of glycosylation sequons and functional role. Pigment Cell and Melanoma Research. June 2011. 24:479-489. 10.1111/j.1755-148X.2011.00848.x
AÑO: 2011; IF: 5.059
|
|
Herraiz C., Journé F., Abdel-Malek Z., Ghanem G., Jiménez-Cervantes C., García-Borrón J.C. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Molecular Endocrinology. January 2011. 25:138-156. 10.1210/me.2010-0217
AÑO: 2011; IF: 4.544
|
|
Herraiz C., Jiménez-Cervantes C., Zanna P., García-Borrón J.C. Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways. FEBS Letters. 6 October 2009. 583:3269-3274. 10.1016/j.febslet.2009.09.023
AÑO: 2009; IF: 3.541
|
|
Sánchez-Laorden B.L., Herraiz C., Valencia J.C., Hearing V.J., Jiménez-Cervantes C., García-Borrón J.C. Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal Golgi. Journal of Cellular Physiology. September 2009. 220:640-654. 10.1002/jcp.21804
AÑO: 2009; IF: 4.586
|